Century Therapeutics, Inc.: shareholders and insiders

IPSCNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$1.65

November 13, 2026Market cap $297M

What Ploutos Investor adds for Century Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 16, 2025 to Nov 5, 2026, from their own Form 4 filings.

22 Form 4s

Bought on the market

$97.0K

2 people

Sold on the market

$86.3K

4 people

From Nov 16, 2025 to Nov 16, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 16, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $68.5K by 2 people

  • 2025: bought $97.0K by 2 people, sold $17.8K by 4 people
  • 2026: no buys, sold $68.5K by 2 people
  • Nov 3, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Sep 14, 2026Gregory RussottiChief Technology and Manufacturing Officer
    Kind
  • Sep 14, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Sep 11, 2026Brent PfeiffenbergerPresident and CEO
    Kind
  • Sep 8, 2026Gregory RussottiChief Technology and Manufacturing Officer
    Kind
  • Sep 8, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Sep 4, 2026Brent PfeiffenbergerPresident and CEO
    Kind
  • Aug 14, 2026Brent PfeiffenbergerPresident and CEO
    Kind
  • Aug 3, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Jun 12, 2026Gregory RussottiChief Technology and Manufacturing Officer
    Kind
  • Jun 12, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Jun 11, 2026Brent PfeiffenbergerPresident and CEO
    Kind
  • Jun 11, 2026Chad CowanChief Scientific Officer
    Kind
  • Jun 8, 2026Gregory RussottiChief Technology and Manufacturing Officer
    Kind
  • Jun 8, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Jun 5, 2026Brent PfeiffenbergerPresident and CEO
    Kind
  • May 4, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Mar 12, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Mar 12, 2026Gregory Russotti
    Kind
  • Mar 9, 2026Douglas CarrSVP Finance & Operations
    Kind
  • Mar 9, 2026Gregory Russotti
    Kind
  • Feb 3, 2026Douglas CarrSVP Finance & Operations
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 9, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by IPSC's officers and directors from 2021 up to November 15, 2025, 5 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

6 Holders over 5%May 15, 2026 Latest filing
  • RA Capital Management, L.P.with 3 more persons
    Share of class9.90%
  • TCG Crossover GP II, LLCwith 4 more persons
    Share of class9.90%
  • Deep Track Capital, LPwith 3 more persons
    Share of class7.34%
  • Commodore Capital LPwith 3 more persons
    Share of class7.10%
  • RTW Investments, LPwith 1 more person
    Share of class7.10%
  • Venrock Healthcare Capital Partners III, L.P.with 6 more persons
    Share of class7.10%
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Point72 Asset Management, L.P.3.30%May 15, 202613G/A
  • Bain Capital Life Sciences Opportunities III, LP4.10%Nov 14, 202513G/A
  • Casdin Capital, LLC3.70%May 15, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter-16%
  • Millennium Mgmt (Englander)
    In the quarter-10%
  • Citadel Advisors (Griffin)
    In the quarter
  • Renaissance Technologies
    In the quarter-15%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 16.2% of its shares outstanding were held short, -0.3% since the report before.

Shares held short
29.13M
16.2%
Since the report before29.22M on Sep 30, 2026
-0.3%
29.2
996.3K
More days to cover thanof 4,578 US-listed companies with enough volume
100%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 842.9K
  • Nov 15, 2023: Shares held short 742.6K
  • Nov 30, 2023: Shares held short 922.0K
  • Dec 15, 2023: Shares held short 888.8K
  • Dec 29, 2023: Shares held short 906.7K
  • Jan 12, 2024: Shares held short 795.6K
  • Jan 31, 2024: Shares held short 846.3K
  • Feb 15, 2024: Shares held short 1.81M
  • Feb 29, 2024: Shares held short 1.75M
  • Mar 15, 2024: Shares held short 1.64M
  • Mar 28, 2024: Shares held short 1.65M
  • Apr 15, 2024: Shares held short 1.73M
  • Apr 30, 2024: Shares held short 1.56M
  • May 15, 2024: Shares held short 1.56M
  • May 31, 2024: Shares held short 1.61M
  • Jun 14, 2024: Shares held short 1.56M
  • Jun 28, 2024: Shares held short 1.79M
  • Jul 15, 2024: Shares held short 2.87M
  • Jul 31, 2024: Shares held short 2.15M
  • Aug 15, 2024: Shares held short 2.23M
  • Aug 30, 2024: Shares held short 2.83M
  • Sep 13, 2024: Shares held short 3.28M
  • Sep 30, 2024: Shares held short 3.49M
  • Oct 15, 2024: Shares held short 3.33M
  • Oct 31, 2024: Shares held short 3.52M
  • Nov 15, 2024: Shares held short 2.26M
  • Nov 29, 2024: Shares held short 2.87M
  • Dec 13, 2024: Shares held short 2.71M
  • Dec 31, 2024: Shares held short 3.09M
  • Jan 15, 2025: Shares held short 3.02M
  • Jan 31, 2025: Shares held short 3.07M
  • Feb 14, 2025: Shares held short 3.13M
  • Feb 28, 2025: Shares held short 3.41M
  • Mar 14, 2025: Shares held short 3.38M
  • Mar 31, 2025: Shares held short 3.13M
  • Apr 15, 2025: Shares held short 3.49M
  • Apr 30, 2025: Shares held short 2.75M
  • May 15, 2025: Shares held short 2.56M
  • May 30, 2025: Shares held short 2.41M
  • Jun 13, 2025: Shares held short 2.32M
  • Jun 30, 2025: Shares held short 1.49M
  • Jul 15, 2025: Shares held short 1.39M
  • Jul 31, 2025: Shares held short 1.34M
  • Aug 15, 2025: Shares held short 1.46M
  • Aug 29, 2025: Shares held short 1.56M
  • Sep 15, 2025: Shares held short 1.46M
  • Sep 30, 2025: Shares held short 1.39M
  • Oct 15, 2025: Shares held short 349.0K
  • Oct 31, 2025: Shares held short 350.5K
  • Nov 14, 2025: Shares held short 497.5K
  • Nov 28, 2025: Shares held short 608.3K
  • Dec 15, 2025: Shares held short 246.3K
  • Dec 31, 2025: Shares held short 325.4K
  • Jan 15, 2026: Shares held short 807.1K
  • Jan 30, 2026: Shares held short 3.39M
  • Feb 13, 2026: Shares held short 4.74M
  • Feb 27, 2026: Shares held short 6.33M
  • Mar 13, 2026: Shares held short 8.63M
  • Mar 31, 2026: Shares held short 10.29M
  • Apr 15, 2026: Shares held short 10.96M
  • Apr 30, 2026: Shares held short 12.05M
  • May 15, 2026: Shares held short 12.21M
  • May 29, 2026: Shares held short 12.47M
  • Jun 15, 2026: Shares held short 15.41M
  • Jun 30, 2026: Shares held short 23.46M
  • Jul 15, 2026: Shares held short 28.38M
  • Jul 31, 2026: Shares held short 29.82M
  • Aug 14, 2026: Shares held short 29.37M
  • Aug 31, 2026: Shares held short 29.53M
  • Sep 15, 2026: Shares held short 29.35M
  • Sep 30, 2026: Shares held short 29.22M
  • Oct 15, 2026: Shares held short 29.13M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading45.8% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 45.8% of the shares in the reported trades were short sales, against 71.0% in the 14 before.

Last 14 sessionsOct 27, 2026 – Nov 13, 2026
45.8%
The 14 beforeOct 7, 2026 – Oct 26, 2026
71.0%
Change
-25.2 pts
Short sales a dayon average, of 419.8K shares
192.4K
More than atof 3,649 US-listed companies, same days
36%
Median of alleight in ten from 34.6% to 63.4%
50.1%
  • Oct 7, 2026: Short sales 22.2%
  • Oct 8, 2026: Short sales 40.2%
  • Oct 9, 2026: Short sales 72.8%
  • Oct 12, 2026: Short sales 61.4%
  • Oct 13, 2026: Short sales 54.6%
  • Oct 14, 2026: Short sales 60.5%
  • Oct 15, 2026: Short sales 53.9%
  • Oct 16, 2026: Short sales 44.9%
  • Oct 19, 2026: Short sales 52%
  • Oct 20, 2026: Short sales 72.4%
  • Oct 21, 2026: Short sales 94.3%
  • Oct 22, 2026: Short sales 95.8%
  • Oct 23, 2026: Short sales 86.6%
  • Oct 26, 2026: Short sales 57%
  • Oct 27, 2026: Short sales 56.9%
  • Oct 28, 2026: Short sales 18.1%
  • Oct 29, 2026: Short sales 69.2%
  • Oct 30, 2026: Short sales 35.9%
  • Nov 2, 2026: Short sales 75.9%
  • Nov 3, 2026: Short sales 47.1%
  • Nov 4, 2026: Short sales 54.1%
  • Nov 5, 2026: Short sales 46.2%
  • Nov 6, 2026: Short sales 8.7%
  • Nov 9, 2026: Short sales 46.3%
  • Nov 10, 2026: Short sales 53.6%
  • Nov 11, 2026: Short sales 62.5%
  • Nov 12, 2026: Short sales 61.4%
  • Nov 13, 2026: Short sales 72%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

6.09M Insiders' shares3.39% Of the company
  • Brent PfeiffenbergerPresident and CEO
    Directly3.63M
  • Chad CowanChief Scientific Officer
    Directly1.19M
  • Gregory RussottiSee Remarks
    Directly509.2K
  • Douglas CarrSVP Finance & Operations
    Directly502.6K
  • Adrienne FaridChief Operations Officer
    Directly250.1K
  • Daphne QuimiDirector
    Directly5,000

A lower bound: it counts only the 6 officers and directors with a market trade since Nov 17, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

6 ETFs holding it0.02% The largest weight (IWN)
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.02%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

6 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

99 Managers, Q2 2026$387M Value of their positions
  • Q3 2025: Managers 57
  • Q4 2025: Managers 47
  • Q1 2026: Managers 73
  • Q2 2026: Managers 99

Institutional investors by quarter

The fund managers holding IPSC, quarter by quarter, from Q2 2021 to Q2 2025, 17 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 99 managers held 158M shares, worth $387M. During the quarter 36 opened a position, 11 closed one, 25 added and 12 trimmed.

The largest holders, Q2 2026

  • TCG Crossover Management
    In the quarter
  • Ra Capital Management
    In the quarter
  • Versant Venture Management
    In the quarter
  • Deep Track Capital
    In the quarter-0.3%
  • Commodore Capital
    In the quarter
  • Venrock Adviser
    In the quarter
  • Rtw Investments
    In the quarter
  • BlackRock
    In the quarter+431%
  • Vanguard Capital Management
    In the quarter+0.3%
  • Balyasny Asset Management
    In the quarter+10%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Century Therapeutics's filings show?

Who buys and sells is one part of Century Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about IPSC's shareholders

Didn't find what you were looking for?

Ask us
Have IPSC's insiders bought or sold?

From Jun 9, 2026 to Nov 5, 2026 Century Therapeutics's insiders bought 0 and sold $21.8K of shares on the market. 0% of the sales were under set 10b5-1 plans.

Which well-known managers hold IPSC?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Point72 (Cohen)'s, worth $12M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.